Primary hypothyroidism is usually caused by autoimmune thyroiditis like Hashimoto's thyroiditis. It results from gradual destruction of the thyroid gland leading to decreased thyroid hormone production. Common symptoms include fatigue, cold intolerance, constipation, and weight gain. Secondary hypothyroidism is caused by pituitary or hypothalamic disease resulting in decreased TSH levels. Both can be confirmed through lab tests showing elevated TSH and low free T4 levels. Treatment involves thyroid hormone replacement therapy.
Hyperthyroidism (overactive thyroid) occurs when your thyroid gland produces too much of the hormone thyroxine. Hyperthyroidism can accelerate your body's metabolism, causing unintentional weight loss and a rapid or irregular heartbeat
Hypothyroidism (underactive thyroid) is a condition in which your thyroid gland doesn't produce enough of certain crucial hormones.
Hyperthyroidism (overactive thyroid) occurs when your thyroid gland produces too much of the hormone thyroxine. Hyperthyroidism can accelerate your body's metabolism, causing unintentional weight loss and a rapid or irregular heartbeat
Hypothyroidism (underactive thyroid) is a condition in which your thyroid gland doesn't produce enough of certain crucial hormones.
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
A complete presentation on hypothroidism endocrine disorder based on latest editon of harrison and reference books. this presentation will help to learn about this second most common endocrine disorder.
Thyroiditis is a general term that refers to “inflammation of the thyroid gland”. Thyroiditis includes a group of individual disorders causing thyroidal inflammation but presenting in different ways. For example, Hashimoto's thyroiditis is the most common cause of hypothyroidism in the United States.
Hyperparathyroidism is medical condition where overactivity of one or more of the body's four parathyroid glands leads to excess of parathyroid hormone in the bloodstream.
DEFINITION
• Myxedema coma is a rare life-threatening condition.It is the decompensated state of severe hypothyroidism in whichthe patient is hypothermic and unconscious.The condition occurs most often among elderly women in the winter months and appears to be precipitated by cold.
• Myxedema coma, occasionally called myxedema crisis, is a rare life- threatening clinical condition that represents severe hypothyroidism with physiological decompensation. The condition usually occurs in patients with long-standing, undiagnosed hypothyroidism and is usually precipitated by infection, cerebrovascular disease, heart failure, trauma, or drug therapy.
• Myxedema is also used to describe the dermatologic changes that occur in hypothyroidism which refers to deposition of mucopolysaccharides in the dermis, which results in swelling of the affected area.
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
A complete presentation on hypothroidism endocrine disorder based on latest editon of harrison and reference books. this presentation will help to learn about this second most common endocrine disorder.
Thyroiditis is a general term that refers to “inflammation of the thyroid gland”. Thyroiditis includes a group of individual disorders causing thyroidal inflammation but presenting in different ways. For example, Hashimoto's thyroiditis is the most common cause of hypothyroidism in the United States.
Hyperparathyroidism is medical condition where overactivity of one or more of the body's four parathyroid glands leads to excess of parathyroid hormone in the bloodstream.
DEFINITION
• Myxedema coma is a rare life-threatening condition.It is the decompensated state of severe hypothyroidism in whichthe patient is hypothermic and unconscious.The condition occurs most often among elderly women in the winter months and appears to be precipitated by cold.
• Myxedema coma, occasionally called myxedema crisis, is a rare life- threatening clinical condition that represents severe hypothyroidism with physiological decompensation. The condition usually occurs in patients with long-standing, undiagnosed hypothyroidism and is usually precipitated by infection, cerebrovascular disease, heart failure, trauma, or drug therapy.
• Myxedema is also used to describe the dermatologic changes that occur in hypothyroidism which refers to deposition of mucopolysaccharides in the dermis, which results in swelling of the affected area.
Hypothyroidism is a disorder that occurs when the thyroid gland does not make enough thyroid hormone to meet the body’s needs.
Hyperthyroidism is a disorder that occurs when the thyroid gland makes more thyroid hormone than the body needs.
in this presentation lecture we gone take a hypo and hyper thyrodism that affect the human cell because both situation may increase or decrease the basal metabolic rate.
Seminar presentation by 5th-year medical students under the supervision of in house lecturer. He was previously working as a consultant surgeon in Syria. Reference as mentioned in the slides.
Seminar presentation by 5th year Medical Student under the supervision of a pediatric surgery specialist from HRPZ II. Reference as mentioned in the slide.
Seminar presentation by group C 5th year medical student under supervision Dato Imi, endocrine specialist in HRPZ II.
Reference as mentioned at the end of the slide presentation
4th year medical student's seminar presentation under supervision of orthopedic lecturer. Reference is from Dr. Sameh Doss Textbook of upper and lower limb, and also other multiple websites.
Seminar presentation by 4th year medical student of Lincoln University College, supervised by HRPZ Orthopedic's specialist.
Reference were from reliable medical websites and also from texttbook; Apley and Solomon's Concise System of Orthopaedics and Trauma, 4th Ed.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
1. T H Y R O I D D I S E A S E S &
E M E R G E N C I E S
P R E S E N T E D B Y
N U R U L H I D A Y U B I N T I I B R A H I M
N U R U L H U S N A B I N T I A Z I Z
M U H A M M A D A F F A N S Y A F I Q I
2. INTRODUCTION
T H Y R O I D D I S E A S E S
Thyroid diseases are amongst one of the most common endocrine diseases in
Malaysia.
Through the hormones it produces, the thyroid gland influences almost all the
metabolic process in the body.
Thyroid diseases can range from a small, harmless goiter that needs no
treatment to life threatening cancer.
The most common thyroid problems involve abnormal production of
hormones which are hyperthyroidism and hypothyroidism.
Although the effects can be unpleasant or uncomfortable, most thyroid
problems can be managed well if properly diagnosed and treated.
3. ANATOMY
T H Y R O I D G L A N D
The thyroid is a butterfly-shaped gland located in the front of the neck just above
the trachea, weighs approximately 15 to 20 grams in the adult human.
It consist of two lobes connected by narrow band thyroid tissues called the isthmus.
Four parathyroid glands located posteriorly at each pole of thyroid gland.
Thyroid gland supplied by:
I. Superior Thyroid Artery – branch of external carotid artery
II. Inferior Thyroid Artery – branch of thyrocervical trunk
III. Thyroid Ima Artery
5. ANATOMY
T H Y R O I D G L A N D
The venous blood is drained via:
Superior thyroid veins
Middle thyroid veins
Inferior thyroid veins – drain into the left and right brachiocephalic veins
drain to the internal jugular vein
Lymphatic drainage:
Prelaryngeal lymph nodes
Pretracheal lymph nodes
Paratracheal lymph nodes
Nerve supply:
The gland receives sympathetic nerve supply from the superior, middle and inferior
cervical ganglion of the sympathetic trunk.
The gland receives parasympathetic nerve supply from the superior laryngeal nerve
and the recurrent laryngeal nerve.
6. ANATOMY
B L O O D S U P P LY O F T H Y R O I D G L A N D
7. ANATOMY
H O R M O N E S O F T H Y R O I D G L A N D
Hormones secreted by thyroid gland:
thyroxine (T4)
triiodothyronine (T3)
The T3 and T4 are created from iodine and
tyrosine
Hormones secreted by parathyroid gland:
calcitonin
All organ systems are affected by thyroid hormones.
Thyroid hormones increase metabolic rate, heart
rate, and ventricle contractility, as well as muscle
and central nervous system (CNS) excitability.
9. PHYSIOLOGY
T H Y R O I D G L A N D
The iodide trapped by the thyroid gland is subsequently oxidized to iodine by the
enzyme thyroid peroxidase.
The iodine then undergoes a series of organic reactions within the thyroid gland to
produce tetraiodothyronine or thyroxine (T4) and triiodothyronine (T3).
T3 is also produced in other tissues such as the pituitary, liver, and kidney by the
removal of an iodine molecule from T4.
T4 is considered to be more of a pro-hormone, while T3 is the most potent thyroid
hormone produced.
T4 and T3are both stored in the thyroglobulin protein of the thyroid gland and
released into the circulation through the action of pituitary derived thyrotropin
(thyroid stimulating hormone or TSH)
11. PHYSIOLOGY
T H Y R O I D G L A N D
Series of organic
reaction:
1. Iodine trapping
2. Synthesis and
secretion of
thyroglobulin
3. Oxidation of iodine
4. Organification of
thyroglobulin
5. Coupling reaction
6. Storage
7. Secretion
12. RISK FACTORS
FA C T O R S T H AT A F F E C T T H Y R O I D F U N C T I O N
13. TYPES
T H Y R O I D D I S E A S E S
H Y P O T H Y R O I D I S M
H Y P E R T H Y R O I D I S M
It occurs when the gland produces excessive amounts of thyroid hormones.
The most common cause is Graves' disease, an autoimmune disorder.
Hypothyroidism is a state of insufficient thyroid hormone production.
Worldwide, the most common cause is iodine deficiency.
Hypothyroidism secondary to iodine deficiency remains the leading cause of
preventable intellectual disability.
In iodine-sufficient regions, the most common cause of hypothyroidism is
Hashimoto's thyroiditis, also an autoimmune disorder.
14. TYPES
T H Y R O I D D I S E A S E S
T H Y R O I D I T I S
T H Y R O I D E M E R G E N C I E S
Thyroid Storm
Myxedema Coma
Autoimmune – Hashimoto’s thyroiditis, Post-partum thyroiditis & Atrophic thyroiditis
Infection – Viral thyroiditis (De Quervain’s thyroiditis)
Physical – Radiation to the neck
Idiopathic – Painless thyroiditis, Riedel’s thyroiditis
16. INTRODUCTION
R I S K FA C TO R S
Autoimmune thyroiditis
Previous Graves' disease
Personal or family history of associated autoimmune disorders (eg, vitiligo,
pernicious anaemia, diabetes mellitus type 1)
Thyroidectomy or other neck surgery
Radioactive iodine therapy
External radiotherapy
Drugs impairing thyroid function
I. Lithium carbonate
II. Amiodarone
Hypothalamic disorders
Pituitary disorders
17. INTRODUCTION
C L A S S I F I C AT I O N O F H Y P OT H Y R O I D I S M
H Y P OT H Y R O I D I S M
P R I M A R Y
( 9 0 % )
S E C O N D A R Y
( C e n t r a l )
S U B C L I N I C A L T R A N S I E N T
High TSH
concentration
Low serum free
thyroxine (T4)
concentration
Low serum T4
concentration
Serum TSH
concentration is
not
appropriately
elevated.
Can be
observed as a
phase of
subacute
thyroiditis
Normal free T4
concentration
Elevated TSH
concentration
Other terms for
this condition
are :
I. Mild
hypothyroidism
II. Early thyroid
failure
III. Preclinical
hypothyroidism
19. PRIMARY HYPOTYROIDISM
AU TO I M M U N E H Y P OT H Y R O I D I S M
Autoimmune hypothyroidism may be associated with a goiter (Hashimoto's,
or goitrous thyroiditis) or, at the later stages of the disease, minimal residual
thyroid tissue (atrophic thyroiditis).
Because the autoimmune process gradually reduces thyroid function, there is
a phase of compensation when normal thyroid hormone levels are
maintained by a rise in TSH. Though some patients may have minor
symptoms, this state is called subclinical hypothyroidism.
Later, unbound T4 levels fall and TSH levels rise further; symptoms become
more readily apparent at this stage (usually TSH >10 mIU/L), which is referred
to as clinical hypothyroidism or overt hypothyroidism.
Celebrities who known to has Hashimoto’s thyroiditis are Gigi Hadid & Kim
Cattrall.
20. PRIMARY HYPOTYROIDISM
PAT H O G E N E S I S
In Hashimoto's thyroiditis, there is a marked lymphocytic infiltration of the
thyroid with germinal center formation, atrophy of the thyroid follicles
accompanied by absence of colloid, and mild to moderate fibrosis.
In atrophic thyroiditis, the fibrosis is much more extensive, lymphocyte
infiltration is less pronounced, and thyroid follicles are almost completely
absent. Atrophic thyroiditis likely represents the end stage of Hashimoto's
thyroiditis rather than a distinct disorder.
Genetic Associations: HLA-DR (3,4,5) & CTLA-4 (Cytotoxic T Lymphocyte
associated antigen 4) polymorphism
Modifying Environmental Factor : Chronic exposure to high iodine diet
21. PRIMARY HYPOTYROIDISM
A S S O C I AT E D C O N D I T I O N S
Other Autoimmune disorders:
Type 1 diabetes mellitus
Addison's disease
Pernicious anemia
Vitiligo
Alopecia areata
Celiac disease
RA, SLE, Sjogren syndrome
Thyroid associated ophthalmopathy( in 5% of pt)
Turner syndrome, Down’s syndrome
Type 1 or 2 polyglandular autoimmune syndrome
22. SECONDARY HYPOTHYROIDISM
I N T R O D U C T I O N
Secondary hypothyroidism is usually diagnosed in the context of other
anterior pituitary hormone deficiencies; isolated TSH deficiency is very rare.
TSH levels may be low, normal, or even slightly increased in secondary
hypothyroidism; the latter is due to secretion of bio inactive forms of TSH.
The diagnosis is confirmed by detecting a low unbound T4
23. HYPOTHYROIDISM
C L I N I C A L M A N I F E S TAT I O N
Patients with Hashimoto's thyroiditis may present with goiter rather than
symptoms of hypothyroidism. It is usually irregular and firm in consistency.
Hypothyroidism is less prominent clinically and better tolerated when there
is a gradual loss of thyroid function (as in most cases of primary
hypothyroidism) than when it develops acutely after thyroidectomy or abrupt
withdrawal of exogenous thyroid hormone.
The symptoms of central hypothyroidism are usually milder & less obvious
than in primary hypothyroidism because of concurrent symptoms of
coexisting hormone deficiencies. i.e. hot flashes due to hypogonadism may
mask the cold intolerance of hypothyroidism.
24. HYPOTHYROIDISM
C L I N I C A L M A N I F E S TAT I O N
M E C H A N I S M SY M P TO M S S I G N S
Slowing of metabolic processes Fatigue, weakness
Cold intolerance
Dypsnea on exertion
Weight gain
Mental retardation (infant)
Constipation
Growth Failure
Slow movement and slow
speech
Delayed relaxation of tendon
reflexes
Bradycardia
Carotenemia
Accumulation of matrix
substances
Dry skin
Hoarseness
Edema
Coarse skin
Puffy facies and loss of
eyebrows
Periorbital edema
Enlargement of the tongue
Other Decreased hearing
Myalgia and paresthesia
Menorrhagia
Arthralgia
Pubertal delay
Diastolic hypertension
Pleural and pericardial
effusions
Ascites
Galactorrhea
25. HYPOTHYROIDISM
D E F F E N R I AT I O N B E T W E E N P R I M A R Y A N D S E C O N D A R Y H Y P O T H Y R O I D I S M
26. HYPOTHYROIDISM
S K I N M A N I F E S TAT I O N
The skin is cool and pale in patients with hypothyroidism because of
decreased blood flow.
The epidermis has an atrophied cellular layer and hyperkeratosis that results
in the characteristic dry roughness of the skin.
Sweating is decreased because of decreases in calorigenesis and acinar gland
secretion.
A yellowish tinge may be present if the patient has carotenemia, while
hyperpigmentation may be seen when primary hypothyroidism is associated
with primary adrenal failure
Hair may be coarse, hair loss is common, and the nails become brittle.
Non-pitting edema (myxedema) occurs in severe hypothyroidism and may be
generalized. It results from infiltration of the skin with glycosaminoglycans
with associated water retention.
Vitiligo and alopecia areata may be present in patients with hypothyroidism
treatment of Graves‘ hyperthyroidism
28. HYPOTHYROIDISM
E Y E S M A N I F E S TAT I O N
Periorbital edema
Thinning of outer third of eyebrows (Madarosis)
Graves' ophthalmopathy may persist when hypothyroidism develops after
treatment of Graves' hyperthyroidism
H A E M ATO LO G I C A L M A N I F E S TAT I O N
Decrease in red blood cell mass
Normochromic, normocytic hypoproliferative anemia
Pernicious anemia occurs in 10 percent of patients with hypothyroidism
caused by chronic autoimmune thyroiditis : macrocytic anemia with marrow
megaloblastosis
Women in the childbearing years may develop iron deficiency anemia,
secondary to menorrhagia.
In patients with IDA and hypothyroidism, combined therapy with
levothyroxine and oral iron supplements results in correction of the anemia,
which may be refractory to treatment with iron alone
29. HYPOTHYROIDISM
C A R D I OVA S C U L A R M A N I F E S TAT I O N
Decrease in cardiac output that is mediated by reductions in heart rate and
contractility
Thyroid hormone regulation of genes coding for specific myocardial enzymes
involved in myocardial contractility and relaxation is responsible for the
decrease in contractility.
Reduced cardiac output probably contributes to decreased exercise capacity
and shortness of breath during exercise.
Hypercholesterolemia, which is caused by a decrease in the rate of cholesterol
metabolism
Diastolic Hypertension, because of an increase in peripheral vascular
resistance. In normotensive patients, blood pressure increases are small
(<150/100).
ECG : Low voltage, sinus bradycardia, non-specific ST-T changes
30. HYPOTHYROIDISM
R E S P I R ATO RY M A N I F E S TAT I O N
Fatigue, shortness of breath on exertion, rhinitis, and decreased exercise
capacity
Hypoventilation occurs because of respiratory muscle weakness and reduced
pulmonary responses to hypoxia and hypercapnia
R E S P I R ATO RY M A N I F E S TAT I O N
Decreased gut motility results in constipation
Decreased taste sensation.
Gastric atrophy due to the presence of anti-parietal cell antibodies
Celiac disease is four times more common in hypothyroid patients
Modest weight gain (despite poor appetite)due to decreased metabolic rate
and accumulation of fluid
31. APPROACH
H OW TO A P P R OA C H PAT I E N T ?
H I S TO RY TA K I N G
P H Y S I C A L E X A M I N AT I O N
L A B I N V E S T I G AT I O N S
32. APPROACH
I N V E S T I G AT I O N S – T H Y R O I D F U N C T I O N T E S T
33. APPROACH
I N V E S T I G AT I O N S – T H Y R O I D F U N C T I O N T E S T
N O R M A L
T H Y R O I D S T I M U L AT I N G H O R M O N E - T S H
FREETHYROXINEorFT4
NORMAL
34.
35. HYPOTHYROIDISM
M A N A G E M E N T
Goal : Normalize TSH level regardless of cause of hypothyroidism
Treatment of choice is thyroxine
TSH should be measured at 6 to 8 weeks after any change in L-thyroxine
brand or dose
Determinants of Thyroxine Requirements:
1. Age
2. Severity and duration of hypothyroidism
3. Weight
4. Malabsorption
5. Pregnancy
6. Presence of cardiac disease
7. Concomitant drug therapy
36. HYPOTHYROIDISM
M A N A G E M E N T
Starting dose for healthy patients <50 years should be at 1.6 mg/kg/day
Starting dose for healthy patients >50 years should be <50 mg/day. Dose
should be increased by 12.5-25 μg/day, if needed, at 6 to 8 weeks intervals.
(Start low and go slow)
Starting dose for patients with heart disease should be 12.5 to 25 μg/day and
increase by 12.5 to 25 μg/day, if needed, at 6 to 8 weeks intervals
37. HYPOTHYROIDISM
C O N D I T I O N S T H AT A LT E R L E VOT H Y R OX I N E R EQ U I R E M E N T S
38. HYPOTHYROIDISM
T R E AT M E N T F O R S U B C L I N I C A L H Y P OT H Y R O I D I S M
Refers to biochemical evidence of thyroid hormone deficiency in patients
who have few or no apparent clinical features of hypothyroidism.
Routine treatment not recommended when TSH levels are below 10 mU/L.
Any elevation of TSH must be sustained over a 3-month period before
treatment is given.
Treatment is administered by starting with a low dose of levothyroxine (25–50
µg/d) with the goal of normalizing TSH. If thyroxine is not given, thyroid
function should be evaluated annually.
There is a risk that patients will progress to overt hypothyroidism, particularly
when the TSH level is elevated and TPO antibodies are present.
40. HYPERTHYROIDISM
I N T R O D U C T I O N
Hyperthyroidism is hyperactivity of thyroid gland with sustained increase in
synthesis and release of thyroid hormones.
Female
Age more than 60 years old
Smoking
Have autoimmune disease
Family history of thyroid disease or
autoimmune disease
History of goiter
Past history of thyroid surgery
Too much iodine intake through food or
medication
R I S K FA C TO R S
41. HYPERTHYROIDISM
A E T I O LO G Y
Common causes of hyperthyroidism include :
Grave disease
Functioning adenoma and toxic multinodular goiter (TMNG)
Excessive intake of thyroid hormones
Abnormal secretion of TSH
Thyroiditis
Excessive iodine intake
45. HYPERTHYROIDISM
D I S E A S E S I N H Y P E R T H Y R O I D I S M
Graves’ Disease
Toxic multinodular Goiter
Toxic adenoma
46. HYPERTHYROIDISM
D I S E A S E S I N H Y P E R T H Y R O I D I S M
Toxic multinodular Goiter
Seen in the elderly and in iodine deficient areas.
There are nodules that secrete thyroid hormones
Compression symptoms such dysphagia or dyspnea
Need surgery for the thyroid that keep on enlarge by removal the nodules
Toxic Adenoma
There is a solitary nodule producing T3 and T4
On isotope scan, the nodule is ‘hot’ and the rest of gland is suppressed
47. GRAVES’ DISEASE
I N T R O D U C T I O N
Also known as toxic diffuse goiter, is an autoimmune disease that affects the
thyroid, presented with enlarged thyroid.
It is the most common cause of hyperthyroidism.
Idiopathic causes :
a) Family history of grave disease
b) Genetic factors
c) Triggered by stress, infection
d) Autoimmune disease (type 1 DM, Addison’s disease)
e) Smoking
48. GRAVES’ DISEASE
PAT H O G E N E S I S
Circulating IgG autoantibodies directed against the thyrotropin receptor
binding to and activating G-protein-coupled thyrotropin receptors, which
cause smooth thyroid enlargement.
This cause increase hormone production especially T3.
React with orbital auto-antigens.
Triggers with stress and infection.
50. GRAVES’ DISEASE
PAT H O G E N E S I S
Production of thyroid hormones is
regulated by TSH.
The binding of TSH to a receptor on
thyroid cells activates adenylate
cyclase and stimulates the synthesis of
2 thyroid hormones : T3 & T4
A person with Grave’s disease makes
auto-antibodies to the receptor for
TSH.
The binding of these auto-antibodies
to the receptor mimics the normal
action of TSH, without the regulation,
leading to overstimulation of the
gland.
The auto-antibodies are called long
acting TSH.
51. GRAVES’ DISEASE
H OW TO A P P R OA C H PAT I E N T ?
History Taking
Physical Examination
W H AT TO I N C LU D E I N H I S TO RY TA K I N G ?
Unexplained weight loss even with good appetite
Excessive sweating especially at night
Cannot tolerance to heat
Excitability, irritability, tremulousness
Palpitations
Any pressure symptoms such as dysphagia, dyspnea and hoarseness of voice
Family history of hyperthyroidism
History of autoimmune disease
History of goiter and past thyroid surgery
History of iodine contrast media use
Smoking or not
Iodine intake history either medication or diet
53. GRAVES’ DISEASE
C L I N I C A L F E AT U R E S
SYMPTOMS
Palpitation, tremor, heat intolerance, sweating,
increase appetite and unintentional weight loss
Eye symptoms (30-50%) : exophthalmos,
opthalmoplagia
Thyroid dermopathy : Pretibial myxedema (7%)
Thickening of the skin, particularly over the lower
tibia due to accumulation of glycosaminoglycan
Thyroid Acropachy - Clubbing of fingers (rare)
54. GRAVES’ DISEASE
H OW TO A P P R OA C H PAT I E N T ?
History Taking
Physical Examination
W H AT TO LO O K F O R I N P H Y S I C A L E X A M I N AT I O N ?
Unilateral neck swelling or
goiter usually with or without
bruit in grave disease
(describe the swelling)
Proximal muscle weakness
Hyperreflexia
Warm and sweaty palms
Palmar erythema
Fine finger tremors
Lid retraction, lid lag,
exophthalmos
Resting tachycardia
56. INVESTIGATION
Full blood count – Hemoglobin (Hb) and Total
White Count (TWC) to rule out sign of infection
Thyroid function test – TSH, T3 and T4
Serum thyroid autoantibodies
Serum calcitonin level
Serum thyroglobulin level
Isotopes scan
Radioactive iodine uptake and scan – to rule out
thyroiditis
Thyroid ultrasound + Colour flow Doppler
I. Ultrasound
Inhomogeneous diffusely
hypoechoic gland
II. Colour Doppler
Hypervascular – Thyroid inferno
60. GRAVES’ DISEASE
H OW TO M A N A G E T H I S PAT I E N T ?
Three forms of therapy are available:
1. Medical Treatment
Anti-thyroid drug
Thionamides (carbimazole or propylthiouracil) are the commonest forms of
treatment that can be used for most patients with the hope of achieve long
term remission.
Also used in preparation for surgery and radioiodine therapy
B- blockers
For symptoms relief initially
Propranolol 30-120mg/day
61. GRAVES’ DISEASE
H OW TO M A N A G E T H I S PAT I E N T ?
Anti-thyroid drug most useful in :
Children It is effective and more acceptable
to patients
Pregnancy The doses should lower as possible
to reduce risk of fetal goiter.
PTU is preferred to carmibazole in
pregnancy and breastfeeding time
Patient with medical complications Thyroid crisis and heart failure
Patient who contraindicated to surgery
or refuse surgery
Patient who relapse after
thyroidectomy
63. GRAVES’ DISEASE
H OW TO M A N A G E T H I S PAT I E N T ?
2. Surgery
Thyroidectomy
Indication :
I. Failed medical treatment; relapse after one and non compliance to anti
thyroid drug
II. With large goiters and pressure symptoms
3. Radioiodine therapy
Contraindicated in pregnant and breastfeed mother
65. INTRODUCTION
Thyroiditis is inflammation of the thyroid gland with destruction of the thyroid
tissues to a variable degree.
The presentation, functional disturbance and prognosis depend on the
aetiology of the thyroiditis.
Presentation may be acute, subacute or chronic.
The causes are:
I. Autoimmune – Hashimoto’s thyroiditis, Post-partum thyroiditis &
Atrophic thyroiditis
II. Infection – Viral thyroiditis (De Quervain’s thyroiditis)
III. Physical – Radiation to the neck
IV. Idiopathic – Painless thyroiditis, Riedel’s thyroiditis
66. THYROIDITIS
T Y P E S
Hashimoto’s thyroiditis presents with diffuse firm goitre.
Patients are usually euthyroid but may develop hypothyroidism in the long
term.
Few patients may present with thyrotoxicosis due to co-existing Graves’
disease. It is more common in females in the fourth and fifth decades.
There is often a positive family history of goitre or other autoimmune
diseases.
H A S H I M OTO ’ S T H Y R O I D I T I S
67. THYROIDITIS
T Y P E S
Postpartum thyroiditis is an autoimmune disorder presenting with
thyrotoxicosis followed by euthyroid and hypothyroid phases a few months
after delivery.
A proportion of patients may present at the hypothyroid phase.
Unlike De Quervain’s, there is no pain in the thyroid which is enlarged in about
50% of cases.
The thyrotoxic phase lasts for about 2 months but the hypothyroid phase may
last for 2-9 months.
About 5% of the patients develop permanent hypothyroidism.
P O S T PA R T U M T H Y R O I D I T I S
PA I N L E S S T H Y R O I D I T I S
Painless thyroiditis is of unknown aetiology and is similar to postpartum
thyroiditis except that this is not associated with pregnancy.
68. THYROIDITIS
T Y P E S
Subacute (De Quervain's) thyroiditis usually presents with pain in the region
of thyroid gland which may be mistaken for pharyngitis accompanied in severe
cases by fever.
Patient may presented with fatigue, difficulty in swallowing and may also
came with accompanying symptoms and signs of thyrotoxicosis.
On palpation, the gland is slightly to moderately enlarged, firm and usually
exquisitely tender. The disease usually passes through a euthyroid phase
followed by a transient hypothyroid phase prior to full recovery within a few
months in the majority of cases.
Rarely, permanent hypothyroidism may result.
D E Q U E RVA I N ’ S T H Y R O I D I T I S
69. THYROIDITIS
T Y P E S
Riedel’s thyroiditis is a rare condition of unknown aetiology presenting with
hypothyroidism and woody hard goitre.
The extensive fibrosis may involve the adjacent structures e.g. trachea and
oesophagus and may be associated with fibrosis elsewhere especially in the
retroperitoneal area.
Some patients may have elevated anti-thyroid antibodies but not as high as
those of Hashimoto’s thyroiditis.
R I E D E L’ S T H Y R O I D I T I S
70. THYROIDITIS
T Y P E S
Acute pyogenic thyroiditis is rare and is usually a result of dissemination from
a septic focus elsewhere.
It usually presents with fever, pain and signs of acute inflammation in the
thyroid gland.
Needle aspiration of the thyroid should be performed for diagnosis and
identification of the organism.
Rarely, tuberculosis or anaplastic carcinoma of the thyroid may present
similarly.
A C U T E P YO G E N I C T H Y R O I D I T I S
71. THYROIDITIS
L A B I N V E S T I G AT I O N S
1. Thyroid function tests
To assess functional status are indicated in all patients with thyroiditis since
some may have subclinical thyroid dysfunction.
Repeat measurements should be performed as thyroid status may change.
2. Other tests to confirm aetiology includes:
Thyroid autoantibodies (anti-thyroid peroxidase and anti-thyroglobulin)
Thyroid aspirate (FNAC) for cytological diagnosis and culture in the case of
pyogenic thyroiditis.
3. Isotope uptake scan is useful in differentiating thyrotoxicosis due to
thyroiditis from Graves’ disease.
4. ESR is raised in De Quervain’s thyroiditis and useful in monitoring activity of
the disease.
72. THYROIDITIS
M A N A G E M E N T
NSAIDs to relieve pain.
In De Quervain’s thyroiditis, if pain persists after 1 week of NSAIDs
treatment, steroid therapy (prednisolone 30 mg/day for 1 week) is
useful.
Antithyroid drugs (e.g. carbimazole) are not indicated.
Beta-blockers may be useful to alleviate symptoms.
73. THYROIDITIS
M A N A G E M E N T
L-thyroxine is indicated for hypothyroidism. It may be withdrawn after
6-12 months in postpartum or painless thyroiditis to determine
whether there is recovery of thyroid function. In Hashimoto’s thyroiditis,
hypothyroidism is likely to be permanent and patients require life-long
thyroid hormone replacement.
Antibiotics are indicated in pyogenic thyroiditis.
Surgical drainage may be required.
75. INTRODUCTION
T H Y R O I D E M E R G E N C I E S
In the USA, the overall incidence of hyperthyroidism is estimated to be
between 0.05% and 1.3%, with the majority of cases being subclinical in terms
of presentation.
Among hospitalized thyrotoxicosis patients, the incidence of thyroid storm has
been noted to be <10%.
The mortality of thyroid storm without treatment ranges between 80% and
100%; with treatment, this figure is between 10% and 50%.
Multiple organ failure was reported to be the most common cause of death
in thyroid storm.
76. TYPES
T H Y R O I D E M E R G E N C I E S
M Y X E D E M A C O M A
T H Y R O I D S T O R M
Thyroid storm represents the extreme presentation of thyrotoxicosis.
An extreme complications of hypothyroidism in which patients exhibit multiple
organ abnormalities and progressive mental deterioration.
Occurs when the body’s compensatory responses to hypothyroidism are
overwhelmed by various precipitating stressors.
Myxedema coma is used to describe the severe life-threatening manifestations of
hypothyroidism.
The term myxedema coma itself is a misnomer, as patients do not usually present
with frank coma but more commonly have altered mental status or mental slowing.
Myxedema actually refers to the non-pitting puffy appearance of the skin and soft
tissues related to hypothyroidism
77. MYXEDEMA COMA
C O M M O N P R E C I P I TAT I N G FA C TO R S
M Y X E D E M A C O M A
I N F E C T I O N S S T R E S S H Y P O V O L E M I A D R U G S
Pneumonia
UTI
Sedative &
Tranquilizers
Amiodarone
Lithium
Narcotics
Diuretics
Anaesthesia
Example : GI
Bleeding, Surgery
Stroke
Acute MI
Trauma
79. MYXEDEMA COMA
C L I N I C A L F E AT U R E S
Primarily a clinical diagnosis with features of uncomplicated hypothyroidism but
more exaggerated. Thyroid hormone levels are similar to those found in
uncomplicated hypothyroidism.
Female at risk
Elderly
Positive symptoms and signs of hypothyroidism – Look for thyroidectomy scar
or features of hypopituitarism:
1. Hypothermia
2. Hypotension, bradycardia
3. Hypoventilation
4. Hyporeflexia
80. MYXEDEMA COMA
C L I N I C A L F E AT U R E S
The cardinal features of myxedema coma are:
1) Hypothermia, which can be profound
2) Altered mental status – Confusion, Delirium, Psychosis, Fit, Coma
3) Cardiovascular depression
The severely hypothyroid patient essentially becomes poikilothermic due to
disordered thermoregulation. This is the reason many cases occur in the winter
months.
Body temperatures as low as 23.3°C have been reported; thus, rectal
temperatures are essential to making the diagnosis.
81. MYXEDEMA COMA
D I A G N O S T I C C R I T E R I A – J O H N H O P S K I N
82. MYXEDEMA COMA
D I A G N O S T I C C R I T E R I A – J O H N H O P S K I N
83. MYXEDEMA COMA
L AB I NV EST I GAT I ONS
1. Full Blood Count –Total White Count and Hb level (Macrocytic Anemia)
2. BUSE – Hyponatremia (usually like SIADH – like picture)
3. Liver Function Test – Elevated transaminases
4. ABG test – Hypercapnia and Hypoxia
5. Lipid profile – Hyperlipidemia
6. Thyroid Function Test
7. Blood C&S – To rule out infections
8. Urine Analysis – microscopic hematuria, leukocytes
9. Urine C&S
B ED SI DE I NV EST I GAT I ONS
ECG – Abnormal ECG: Prolonged PR, QRS and QT, abnormal T wave and
arrhythmias.
Random Blood Sugar test – Hypoglycemia
I MAGI NG
Chest Xray – Pericardial effusion ± pleural effusion
85. MYXEDEMA COMA
MANAGEMENT
1. Treatment should be started on clinical grounds.
If in genuine doubt, it is worth treating as myxedema coma, as giving L-
tyroxine judiciously is unlikely to be harmful in the short term.
Ideally patient should be managed in ICU.
2. Thyroid hormone replacement
Replacement therapy should be gentle if patients are elderly and at risk of
cardiac arrhythmias, heart failure or myocardial ischemia.
Whether T3 or T4 or both should be given is controversial.
Reason:
A. T3 is has faster onset of action and is the active hormone. T4 has a much
longer half-life, more gradual onset of action and is converted to T3
endogenously.
B. Use of T4 avoids a sudden rise in active T3, which may have adverse
cardiac effects in patients at risk. However, conversion T4 T3 may be
impaired in critically ill patient.
86. MYXEDEMA COMA
MANAGEMENT
Reason:
C. Oral T4 has variable oral bioavailability of 40-80%. Avoid co-
administration with antacid, calcium or iron supplement. In contrast oral
T3 has almost 100% oral bioavailability even in hypothyroid patient.
If ischemic heart disease is suspected, dosages of both the above should
be halved.
T4 IV 200 – 500 µg bolus or oral by NG tube followed by
daily dose of 50 – 100 µg until patient can take orally.
(Oral T4 may be given if T3 or IV T4 is not available
but the action is too slow)
T3 IV or oral by NG tube 10 – 20 µg 8 – 12 hourly until T4
can be given orally.
87. MYXEDEMA COMA
MANAGEMENT
3. Steroids
All patients should be given 100 mg hydrocortisone IV stat and then 50 – 100 mg
6 – 8 hourly until adrenal insufficiency (due to Addison’s disease or
hypothyroidism) has been ruled out.
4. Ventilation
If Pa02 is <60 mmHg with O2 or if PaCO2 is >60 mmHg, assisted ventilation may
be required.
5. Treat accordingly :
Hypothermia
Passive external rewarming. Do not
warm the patient rapidly as this may
cause cardiovascular collapse.
Use a lots of blankets and monitor the
rectal temperature.
Do not correct faster than 1°C/Hour.
88. MYXEDEMA COMA
MANAGEMENT
Hypothermia
A low reading thermometer should be
used.
Give warm humidified oxygen by
facemask.
Hypoglycemia
Should be corrected
Exclude concurrent adrenal or pituitary
insufficiency.
Hyponatremia
Usually resolved with thyroxine
replacement and careful attention to
fluid status.
If Na <110 mmol/L, hypertonic saline
may be given, with a maximal correction
of serum sodium by not more than 10
mmol/24 hour period.
89. MYXEDEMA COMA
6. Cardiovascular
Myxedema patients have:
I. Reduction in total blood volume due to chronic vasoconstriction to preserve
body core temperature
II. Depressed cardiac function and reduced responsiveness to catecholamine.
Hence, they tolerate further volume loss (in GI bleed, diuretic, vasodilation
due to sepsis or rapid rewarming) poorly resulting in hypotension.
If necessary, plasma expanders or blood products should be given cautiously
guided by CVP.
Cardiac monitor for supraventricular arrhythmias.
7. Remove or treat precipitating causes. Cover with IV antibiotic if in doubt.
8. Monitor rectal temperature, oxygen saturation, BP, CVP and urine output.
9. On full recovery, doses of replacement thyroxine should be titrated to
maintain an euthyroid state.
90. THYROID STORM
I N T R O D U C T I O N
Thyroid storm also referred to as
thyrotoxic crisis, is an acute, life
threatening hypermetabolic state
induced by excessive release of
TSH in individuals with
thyrotoxicosis.
It is a decompensated state of
thyroid hormone - involving
multiple systems and is the most
extreme state of thyrotoxicosis.
The condition is rare, however,
mortality rates are high and may
approach 10-20%.
PERCI PI TAT I NG FAC TORS
Infections
Surgery
Poorly prepared thyroid surgery
Diabetic ketoacidosis
Radioiodine therapy in poorly
prepared patient
Trauma
Myocardial Infarction
Drug : Amiodarone
Discontinuation of anti-thyroid
drugs
Labour
91. THYROID STORM
PAT H O P H Y S I O LO G Y
The detailed pathophysiology is not fully understood, but it is thought to be
related to increased numbers of beta-adrenergic receptors being exposed to
increased catecholamine levels in states of stress.
U N D E R LY I N G C AU S E S O F T H Y R OTOX I C O S I S T H AT P R E D I S P O S E TO
T H Y R O I D S TO R M
Graves’ Disease
Solitory toxic adenoma
Thyroid carcinoma
TSH – secreting pituitary adenoma
Hyadatiform mole
Iodine exposure (IV radiocontrast dye, amiodarone)
92. THYROID STORM
C L I N I C A L F E AT U R E S
Diagnosis is primarily clinical based on high index of suspicion and there are
several factors may precipitate the progression of thyrotoxicosis to thyroid storm.
Thermoregulatory : High fever, sweating
CNS dysfunction : Agitation, confusion, acute psychosis, coma
Cardiovascular : Tachycardia, AF, heart failure
GIT : Diarrhea and vomiting, acute abdominal pain, jaundice and hepatic
dysfunction.
The combination sign and symptoms makes the diagnosis of thyroid storm, and to
produce scoring systems to improve diagnostic accuracy.
Burch-Wartofsky point scale
Japan Thyroid Association categories of thyroid storm 2012
S c o r i n g s y s t e m m u s t n o t b e u s e d a m o n g p a t i e n t s w i t h o u t s e v e r e
t hy r o t ox i c o s i s .
93. THYROID STORM
D I A G N O S I T I C C R I T E R I A – B U R C H - WA R TO F S K Y P O I N T S C A L E
94. THYROID STORM
D I A G N O S I T I C C R I T E R I A – B U R C H - WA R TO F S K Y P O I N T S C A L E
95. THYROID STORM
JA PA N T H Y R O I D A S S O C I AT I O N C AT E G O R I E S O F T H Y R O I D S TO R M
96. THYROID STORM
I N V E S T I G AT I O N S
Full Blood Count – Total white count, Hemoglobin level
BUSE – dehydration status
Blood Glucose - Hypoglycemia
Liver Function Test
Thyroid Function Test
Other additional test to investigate the precipitants
PERCI PI TAT I NG FAC TORS
Infections
Diabetic ketoacidosis
Myocardial Infarction
97. THYROID STORM
M A N A G E M E N T
Mortality of untreated storm is high; if the diagnosis is suspected, anti-thyroid
treatment must be started before biochemical confirmation.
Ideally patient should be managed in ICU.
Hyperthyroidism
A. Inhibition of thyroid hormone formation:
P r o p y l t h i o u ra c i l ( P T U ) C a r b i m a zo l e
Loading dose 600 mg stat and 90-1200
mg/day orally
OR
NG tube in 4-6 divided doses
(e.g 200 mg 4 hourly reduced to 100-200
mg, 6-8 hourly after 24-48 hour)
PTU may be preferable to Carbimazole as
it has the additional action of inhibiting
peripheral conversion of T4 to T3.
60-120 mg/day in 3-4 divided doses
orally or NG tube
99. THYROID STORM
M A N A G E M E N T
Hyperthyroidism
B. Inhibition of thyroid hormone release:
S O D I U M I O D I D E
IV 1 g/24 hour by slow infusion
O R A L P OTA S S I U M I O D I D E
100 mg 6 hourly
O R
O R A L LU G O L’ S I O D I N E
10 – 20 drops 8 hourly
O R
Iodine should be given at least one hour after the patient has received the initial
dose of PTU or carbimazole; this is to ensure that the iodine given is not taken up
by the gland for further thyroid hormone synthesis and release.
100. THYROID STORM
M A N A G E M E N T
Steroids
IV dexamethasone 2 mg 6 hourly. Dexamethasone inhibits both release of
thyroid hormones and peripheral conversion of T4 to T3.
Receptors blockade (in the absence of heart failure)
P R O PA N O LO L
I V P r o p a n o l o l 1 - 2 m g s l o w l y 4 - 6
h o u r l y
O R
O r a l p r o p r a n o l o l 4 0 - 6 0 m g 6
h o u r l y
Should not be used if there is
pulmonary or peripheral oedema and if
heart failure supervenes, atropine 0.4-1
mg IV should be given.
Assessment of LV function will help
guide the use of beta-blockers.
101. THYROID STORM
M A N A G E M E N T
Receptors blockade (in the absence of heart failure)
D i l t i a ze m
6 0 - 1 2 0 m g 6 h o u r l y
Pulmonery Oedema can be used if beta
blockade is contraindicated e.g bronchial
asthma.
I V E s m o l o l May be useful in difficult case to allow
rapid titration due to its short half life.
Cardiac Failure
Usually associated with fast AF
Diuretics, digoxin, oxygen as appropriate and propranolol if cardiac failure is due to
uncontrolled AF and LV function is good.
There is relative digoxin resistance with increased renal excretion and decreased action
on AV conduction, so a higher dose of digoxin may be needed.
Cardioversion of AF is very unlikely to be successful and should wait until patient is
euthyroid and Amiodarone may be useful when given parentally to control acute
arrhythmias.
102. THYROID STORM
M A N A G E M E N T
Hyperpyrexia
Fans, tepid sponge, and paracetamol.
Dehydration
Cautious replacement of fluid. CVP line is helpful.
Anticoagulation
Give heparin by infusion in patients with AF.
Other patients should receive SC heparin 5000U 2 times daily or LMWH as
prophylaxis against venous thromboembolism.
Remove or treat precipitating factors
Exchange transfusion of Peritoneal Dialysis/Hemodialysis
This may be considered in patient who is resistant to the usual
pharmacological measures.
105. REFERENCES
1. Harrison’s Principles of internal medicine – 18th Edition
2. Sarawak Handbook of Medical Emergencies 3rd Edition
3. Malaysian CPG 2000
4. UpToDate.com
5. Publications from the American Thyroid Association, American Association of
Clinical Endocrinologists, and the Endocrine Society
6. National Center for Biotechnology Information
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667251/]